Cameco Corp. Stock
€84.32
Your prediction
Cameco Corp. Stock
Pros and Cons of Cameco Corp. in the next few years
Pros
Cons
Performance of Cameco Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cameco Corp. | 0.640% | 8.158% | 0.285% | 27.526% | 6.465% | 170.777% | 462.133% |
| Laramide Resources Ltd | 0.740% | 12.252% | 6.604% | 10.244% | 2.417% | 10.966% | 5.772% |
| Blue Sky Uranium Corp. | 0.000% | 0.000% | 0.000% | -8.553% | 8.594% | -25.269% | -73.524% |
| Global Crossing Airlines Group Inc. | 1.980% | 5.533% | 11.472% | -2.830% | 20.327% | -6.364% | -72.780% |
sharewise BeanCounterBot AI-generated
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.When examining the financials of Cameco Corporation (US symbol: CCJ), which operates in the uranium industry, a nuanced picture emerges. The company’s financial statements indicate healthy revenue generation but also present challenges, particularly regarding profitability margins and significant debt levels. As a leader in uranium production, Cameco is well-positioned in a sector that is increasingly gaining attention due to renewed interest in nuclear energy. However, as any thorough analysis will reveal, the implications of the financial ratios require a closer look.
Strong Revenue Base: Cameco has reported a total revenue of CAD 2.59 billion for 2023, indicating solid operational performance. The revenue generation reflects the company's robust demand and market position within the uranium sector, which is attractive for growth potential.
Positive EBITDA Figures: The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) stands at CAD 502 million. This figure underscores the operational efficiency of Cameco, suggesting that the company can generate substantial earnings from its core activities. A healthy EBITDA is often viewed as an indicator of a firm's profitability before non-operational expenses are factored in.
Comments
News
Cameco vs. Uranium Energy: Which Uranium Stock Wins the Nuclear Restart?
The nuclear energy market fizzled out for roughly a decade after the 2011 Fukushima disaster, as cautious governments and utilities paused their nuclear expansion plans.
But over the past few
Why Cameco's Ugly Earnings Miss Might Be Good News in Disguise
Cameco (NYSE: CCJ) recently reported ugly second-quarter results. The nuclear fuel supplier's revenue fell 7%, while its adjusted earnings per share missed the analysts' consensus estimate by a mile
Cameco Q2 Earnings Call Highlights
Key Points
- Interested in Cameco Corporation? Here are five stocks we like better.
- Cameco maintained its 2026 production outlook of 19.5 million to 21.5 million pounds of U3O8 despite
